{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:21:37Z","timestamp":1782829297509,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Doctoral Fund of the First Affiliated Hospital of Harbin Medical University","award":["2020B22"],"award-info":[{"award-number":["2020B22"]}]},{"name":"The key research and development project of Heilongjiang Province","award":["2023ZX07D06"],"award-info":[{"award-number":["2023ZX07D06"]}]},{"name":"Innovative Scientific Research Funding Project of Harbin Medical University","award":["2022-KYYWF-0301"],"award-info":[{"award-number":["2022-KYYWF-0301"]}]},{"name":"Natural Science Foundation of Heilongjiang Province,China\u9ed1\u9f99\u6c5f\u7701\u81ea\u7136\u79d1\u5b66\u57fa\u91d1","award":["PL2024H140"],"award-info":[{"award-number":["PL2024H140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02105-5","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:44:13Z","timestamp":1759477453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative genomics and functional immunology reveal Clostridia species as modulators of neuroinflammation in amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"74","author":[{"given":"Shuyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8412-3793","authenticated-orcid":false,"given":"Ting","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"2105_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.27126","volume":"97","author":"R Bedlack","year":"2025","unstructured":"Bedlack R, Li X, Evangelista BA, Panzetta ME, Kwan J, Gittings LM, et al. The scientific and therapeutic rationale for off-label treatments in amyotrophic lateral sclerosis. Ann Neurol. 2025;97:15\u201327.","journal-title":"Ann Neurol"},{"key":"2105_CR2","doi-asserted-by":"crossref","first-page":"e00469","DOI":"10.1016\/j.neurot.2024.e00469","volume":"21","author":"M Kaul","year":"2024","unstructured":"Kaul M, Mukherjee D, Weiner HL, Cox LM. Gut microbiota immune cross-talk in amyotrophic lateral sclerosis. Neurotherapeutics. 2024;21:e00469.","journal-title":"Neurotherapeutics"},{"key":"2105_CR3","doi-asserted-by":"crossref","first-page":"e00441","DOI":"10.1016\/j.neurot.2024.e00441","volume":"21","author":"J Sun","year":"2024","unstructured":"Sun J, Zhang Y. Microbiome and micronutrient in ALS: from novel mechanisms to new treatments. Neurotherapeutics. 2024;21:e00441.","journal-title":"Neurotherapeutics"},{"key":"2105_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.14336\/AD.2023.0524","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Cai X, Lao L, Wang Y, Su H, Sun H. Brain-gut-microbiota axis in amyotrophic lateral sclerosis: a historical overview and future directions. Aging Dis. 2024;15:74.","journal-title":"Aging Dis"},{"key":"2105_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89\u201394.","journal-title":"Nature"},{"key":"2105_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474\u201380.","journal-title":"Nature"},{"key":"2105_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40168-022-01232-z","volume":"10","author":"LM Cox","year":"2022","unstructured":"Cox LM, Calcagno N, Gauthier C, Madore C, Butovsky O, Weiner HL. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome. 2022;10:47.","journal-title":"Microbiome"},{"key":"2105_CR8","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1007\/s12035-024-03988-x","volume":"61","author":"Z Xin","year":"2024","unstructured":"Xin Z, Xin C, Huo J, Liu Q, Dong H, Li R, et al. Neuroprotective effect of a multistrain probiotic mixture in SOD1G93A mice by reducing SOD1 aggregation and targeting the microbiota-gut-brain axis. Mol Neurobiol. 2024;61:10051\u201371.","journal-title":"Mol Neurobiol"},{"key":"2105_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","volume":"206","author":"R Zhang","year":"2009","unstructured":"Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2009;206:121\u20134.","journal-title":"J Neuroimmunol"},{"key":"2105_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cjp2.297","volume":"9","author":"SB Pattle","year":"2023","unstructured":"Pattle SB, O\u2019shaughnessy J, Kantelberg O, Rifai OM, Pate J, Nellany K, et al. PTDP-43 aggregates accumulate in non-central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical phenotypic data. J Pathol Clin Res. 2023;9:44\u201355.","journal-title":"J Pathol Clin Res"},{"key":"2105_CR11","doi-asserted-by":"crossref","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, T\u00f3th M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263ra158-263ra158.","journal-title":"Sci Transl Med"},{"key":"2105_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1\u201322.","journal-title":"Int J Epidemiol"},{"key":"2105_CR13","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"key":"2105_CR14","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925\u20136.","journal-title":"JAMA"},{"key":"2105_CR15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BA, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614\u201321.","journal-title":"JAMA"},{"key":"2105_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-021-00992-y","volume":"54","author":"EA Lopera-Maya","year":"2022","unstructured":"Lopera-Maya EA, Kurilshikov A, van der Graaf A, Hu S, Andreu-Sanchez S, Chen L, et al. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project. Nat Genet. 2022;54:143\u201351.","journal-title":"Nat Genet"},{"key":"2105_CR17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345.","journal-title":"Nat Genet"},{"key":"2105_CR18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.neuron.2018.02.027","volume":"97","author":"A Nicolas","year":"2018","unstructured":"Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1267\u201388.","journal-title":"Neuron"},{"key":"2105_CR19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.12688\/wellcomeopenres.16374.2","volume":"5","author":"JR Broadbent","year":"2020","unstructured":"Broadbent JR, Foley CN, Grant AJ, Mason AM, Staley JR, Burgess S. MendelianRandomization v0. 5.0: updates to an R package for performing Mendelian randomization analyses using summarized data. Wellcome Open Res. 2020;5:252.","journal-title":"Wellcome Open Res"},{"key":"2105_CR20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36:465\u201378.","journal-title":"Eur J Epidemiol"},{"key":"2105_CR21","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen S-H, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"key":"2105_CR22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nbt.3960","volume":"35","author":"PI Costea","year":"2017","unstructured":"Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35:1069\u201376.","journal-title":"Nat Biotechnol"},{"key":"2105_CR23","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081.","journal-title":"PLoS Genet"},{"key":"2105_CR24","doi-asserted-by":"crossref","first-page":"884298","DOI":"10.3389\/fcimb.2022.884298","volume":"12","author":"J-S Tan","year":"2022","unstructured":"Tan J-S, Ren J-M, Fan L, Wei Y, Hu S, Zhu S-S, et al. Genetic predisposition of anti-cytomegalovirus immunoglobulin G levels and the risk of 9 cardiovascular diseases. Front Cell Infect Microbiol. 2022;12:884298.","journal-title":"Front Cell Infect Microbiol"},{"key":"2105_CR25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"2105_CR26","first-page":"1","volume":"27","author":"VK Sharma","year":"2025","unstructured":"Sharma VK. Dysbiosis and neurodegeneration in ALS: unraveling the gut-brain axis. Neuromolecular Med. 2025;27:1\u201323.","journal-title":"Neuromolecular Med"},{"key":"2105_CR27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s40478-024-01877-x","volume":"12","author":"E Niccolai","year":"2024","unstructured":"Niccolai E, Di Gloria L, Trolese MC, Fabbrizio P, Baldi S, Nannini G, et al. Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice. Acta Neuropathol Commun. 2024;12:174.","journal-title":"Acta Neuropathol Commun"},{"key":"2105_CR28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/biomedicines9070753","volume":"9","author":"E Niccolai","year":"2021","unstructured":"Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, et al. The gut microbiota-immunity axis in ALS: a role in deciphering disease heterogeneity? Biomedicines. 2021;9:753.","journal-title":"Biomedicines"},{"key":"2105_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.irn.2025.04.006","volume":"180","author":"S Manusha","year":"2025","unstructured":"Manusha S, Varsha N, Varshini R, Sivamani Y, Pokkuluri KS, Elayaperumal S. Altered microbiome influence on the enteric neuromuscular system in amyotrophic lateral sclerosis (ALS). Int Rev Neurobiol. 2025;180:95\u2013123.","journal-title":"Int Rev Neurobiol"},{"key":"2105_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","volume":"22","author":"K Nicholson","year":"2021","unstructured":"Nicholson K, Bjornevik K, Abu-Ali G, Chan J, Cortese M, Dedi B, et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:186\u201394.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2105_CR31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12883-022-02586-5","volume":"22","author":"HS Kim","year":"2022","unstructured":"Kim HS, Son J, Lee D, Tsai J, Wang D, Chocron ES, et al. Gut-and oral-dysbiosis differentially impact spinal-and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurol. 2022;22:62.","journal-title":"BMC Neurol"},{"key":"2105_CR32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","volume":"39","author":"Y-g Zhang","year":"2017","unstructured":"Zhang Y-g, Wu S, Yi J, Xia Y, Jin D, Zhou J, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322\u201336.","journal-title":"Clin Ther"},{"key":"2105_CR33","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1038\/s41598-024-59250-w","volume":"14","author":"ZSW Chui","year":"2024","unstructured":"Chui ZSW, Chan LML, Zhang EWH, Liang S, Choi EPH, Lok KYW, et al. Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis. Sci Rep. 2024;14:9558.","journal-title":"Sci Rep"},{"key":"2105_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40035-024-00404-1","volume":"13","author":"Y-Y Ma","year":"2024","unstructured":"Ma Y-Y, Li X, Yu J-T, Wang Y-J. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside. Transl Neurodegener. 2024;13:12.","journal-title":"Transl Neurodegener"},{"key":"2105_CR35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/cells13070643","volume":"13","author":"L Tamberi","year":"2024","unstructured":"Tamberi L, Belloni A, Pugnaloni A, Rippo MR, Olivieri F, Procopio AD, et al. The influence of myeloid-derived suppressor cell expansion in neuroinflammation and neurodegenerative diseases. Cells. 2024;13:643.","journal-title":"Cells"},{"key":"2105_CR36","doi-asserted-by":"crossref","first-page":"1365673","DOI":"10.3389\/fimmu.2024.1365673","volume":"15","author":"A Warren","year":"2024","unstructured":"Warren A, Nyavor Y, Zarabian N, Mahoney A, Frame LA. The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature. Front Immunol. 2024;15:1365673.","journal-title":"Front Immunol"},{"key":"2105_CR37","doi-asserted-by":"crossref","first-page":"117905","DOI":"10.1016\/j.biopha.2025.117905","volume":"184","author":"M Rob","year":"2025","unstructured":"Rob M, Yousef M, Lakshmanan AP, Mahboob A, Terranegra A, Chaari A. Microbial signatures and therapeutic strategies in neurodegenerative diseases. Biomed Pharmacother. 2025;184:117905.","journal-title":"Biomed Pharmacother"},{"key":"2105_CR38","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/microorganisms8111715","volume":"8","author":"S Stojanov","year":"2020","unstructured":"Stojanov S, Berlec A, \u0160trukelj B. The influence of probiotics on the firmicutes\/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 2020;8:1715.","journal-title":"Microorganisms"},{"key":"2105_CR39","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138:2486\u201398.","journal-title":"Circulation"},{"key":"2105_CR40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","volume":"165","author":"T Vatanen","year":"2016","unstructured":"Vatanen T, Kostic AD, d\u2019Hennezel E, Siljander H, Franzosa EA, Yassour M, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165:842\u201353.","journal-title":"Cell"},{"key":"2105_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104158","author":"TD Horvath","year":"2022","unstructured":"Horvath TD, Ihekweazu FD, Haidacher SJ, Ruan W, Engevik KA, Fultz R, et al. Bacteroides ovatus colonization influences the abundance of intestinal short chain fatty acids and neurotransmitters. iScience. 2022. https:\/\/doi.org\/10.1016\/j.isci.2022.104158.","journal-title":"iScience"},{"key":"2105_CR42","volume":"12","author":"Y Yan","year":"2020","unstructured":"Yan Y, Nguyen LH, Franzosa EA, Huttenhower C. Strain-level epidemiology of microbial communities and the human microbiome. Genome Med. 2020;12:71.","journal-title":"Genome Med"},{"key":"2105_CR43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mehy.2017.05.022","volume":"104","author":"K Berstad","year":"2017","unstructured":"Berstad K, Berstad JE. Parkinson\u2019s disease; the hibernating spore hypothesis. Med Hypotheses. 2017;104:48\u201353.","journal-title":"Med Hypotheses"},{"key":"2105_CR44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/CM9.0000000000002701","volume":"137","author":"K Liu","year":"2024","unstructured":"Liu K, Guo Q, Ding Y, Luo L, Huang J, Zhang Q. Alterations in nasal microbiota of patients with amyotrophic lateral sclerosis. Chin Med J. 2024;137:162\u201371.","journal-title":"Chin Med J"},{"key":"2105_CR45","doi-asserted-by":"crossref","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","volume":"2","author":"DR Beers","year":"2017","unstructured":"Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, et al. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530.","journal-title":"JCI Insight"},{"key":"2105_CR46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamaneurol.2018.0035","volume":"75","author":"RK Sheean","year":"2018","unstructured":"Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D, et al. Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model. JAMA Neurol. 2018;75:681\u20139.","journal-title":"JAMA Neurol"},{"key":"2105_CR47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","volume":"134","author":"DR Beers","year":"2011","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293\u2013314.","journal-title":"Brain"},{"key":"2105_CR48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","volume":"5","author":"JS Henkel","year":"2013","unstructured":"Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5:64\u201379.","journal-title":"EMBO Mol Med"},{"key":"2105_CR49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.1800976","volume":"203","author":"BT Stocks","year":"2019","unstructured":"Stocks BT, Wilson CS, Marshall AF, Hoopes EM, Moore DJ. Regulation of diabetogenic immunity by IL-15\u2013activated regulatory CD8 T cells in type 1 diabetes. J Immunol. 2019;203:158\u201366.","journal-title":"J Immunol"},{"key":"2105_CR50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1000800","volume":"186","author":"AT Endharti","year":"2011","unstructured":"Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S, Ito M, et al. CD8+ CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis. J Immunol. 2011;186:41\u201352.","journal-title":"J Immunol"},{"key":"2105_CR51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4049\/jimmunol.180.2.825","volume":"180","author":"Y-H Lee","year":"2008","unstructured":"Lee Y-H, Ishida Y, Rifa\u2019i M, Shi Z, Isobe K-i, Suzuki H. Essential role of CD8+ CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol. 2008;180:825\u201332.","journal-title":"J Immunol"},{"key":"2105_CR52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/eji.202048614","volume":"51","author":"V Niederlova","year":"2021","unstructured":"Niederlova V, Tsyklauri O, Chadimova T, Stepanek O. CD8+ Tregs revisited: a heterogeneous population with different phenotypes and properties. Eur J Immunol. 2021;51:512\u201330.","journal-title":"Eur J Immunol"},{"key":"2105_CR53","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","volume":"10","author":"TS Kapellos","year":"2019","unstructured":"Kapellos TS, Bonaguro L, Gem\u00fcnd I, Reusch N, Saglam A, Hinkley ER, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10:2035.","journal-title":"Front Immunol"},{"key":"2105_CR54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-016-1548-y","volume":"132","author":"L Zondler","year":"2016","unstructured":"Zondler L, M\u00fcller K, Khalaji S, Bliederh\u00e4user C, Ruf WP, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391\u2013411.","journal-title":"Acta Neuropathol"},{"key":"2105_CR55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","volume":"74","author":"W Zhao","year":"2017","unstructured":"Zhao W, Beers DR, Hooten KG, Sieglaff DH, Zhang A, Kalyana-Sundaram S, et al. Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes. JAMA Neurol. 2017;74:677\u201385.","journal-title":"JAMA Neurol"},{"key":"2105_CR56","doi-asserted-by":"crossref","first-page":"e25545","DOI":"10.1371\/journal.pone.0025545","volume":"6","author":"G Nardo","year":"2011","unstructured":"Nardo G, Pozzi S, Pignataro M, Lauranzano E, Spano G, Garbelli S, et al. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS ONE. 2011;6:e25545.","journal-title":"PLoS ONE"},{"key":"2105_CR57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.24304","volume":"77","author":"O Butovsky","year":"2015","unstructured":"Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, et al. Targeting mi R-155 restores abnormal microglia and attenuates disease in SOD 1 mice. Ann Neurol. 2015;77:75\u201399.","journal-title":"Ann Neurol"},{"key":"2105_CR58","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/ijms23063370","volume":"23","author":"O Yildiz","year":"2022","unstructured":"Yildiz O, Schroth J, Lombardi V, Pucino V, Bobeva Y, Yip PK, et al. The expression of active CD11b monocytes in blood and disease progression in amyotrophic lateral sclerosis. Int J Mol Sci. 2022;23:3370.","journal-title":"Int J Mol Sci"},{"key":"2105_CR59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41593-021-00975-6","volume":"25","author":"M Xie","year":"2022","unstructured":"Xie M, Liu YU, Zhao S, Zhang L, Bosco DB, Pang Y-P, et al. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. Nat Neurosci. 2022;25:26\u201338.","journal-title":"Nat Neurosci"},{"key":"2105_CR60","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.3390\/ijms21197015","volume":"21","author":"PJ Eggenhuizen","year":"2020","unstructured":"Eggenhuizen PJ, Ng BH, Ooi JD. Treg enhancing therapies to treat autoimmune diseases. Int J Mol Sci. 2020;21:7015.","journal-title":"Int J Mol Sci"},{"key":"2105_CR61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19:108\u201319.","journal-title":"Nat Immunol"},{"key":"2105_CR62","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.4049\/jimmunol.1401936","volume":"194","author":"HJ Park","year":"2015","unstructured":"Park HJ, Park JS, Jeong YH, Son J, Ban YH, Lee B-H, et al. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells. J Immunol. 2015;194:5801\u201311.","journal-title":"J Immunol"},{"key":"2105_CR63","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.celrep.2016.11.062","volume":"17","author":"C-R Lee","year":"2016","unstructured":"Lee C-R, Kwak Y, Yang T, Han JH, Park S-H, Ye MB, et al. Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF-\u03b2 during murine colitis. Cell Rep. 2016;17:3219\u201332.","journal-title":"Cell Rep"},{"key":"2105_CR64","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fimmu.2017.00783","volume":"8","author":"A Le Page","year":"2017","unstructured":"Le Page A, Garneau H, Dupuis G, Frost EH, Larbi A, Witkowski JM, et al. Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild Alzheimer diseased patients. Front Immunol. 2017;8:783.","journal-title":"Front Immunol"},{"key":"2105_CR65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2017.03.045","volume":"648","author":"S Chen","year":"2017","unstructured":"Chen S, Liu Y, Niu Y, Xu Y, Zhou Q, Xu X, et al. Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson\u2019s disease patients. Neurosci Lett. 2017;648:21\u20135.","journal-title":"Neurosci Lett"},{"key":"2105_CR66","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.12659\/MSM.904240","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Guo C, Zhu J, Feng Y, Chen W, Feng Z, et al. Increased levels of pro-inflammatory and anti-inflammatory cellular responses in Parkinson\u2019s disease patients: search for a disease indicator. Med Sci Monit. 2017;23:2972.","journal-title":"Med Sci Monit"},{"key":"2105_CR67","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41590-018-0237-5","volume":"19","author":"B Knier","year":"2018","unstructured":"Knier B, Hiltensperger M, Sie C, Aly L, Lepennetier G, Engleitner T, et al. Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity. Nat Immunol. 2018;19:1341\u201351.","journal-title":"Nat Immunol"},{"key":"2105_CR68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00401-023-02593-x","volume":"146","author":"MC Ortega","year":"2023","unstructured":"Ortega MC, Lebron-Galan R, Mach\u00edn-D\u00edaz I, Naughton M, P\u00e9rez-Molina I, Garc\u00eda-Arocha J, et al. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis. Acta Neuropathol. 2023;146:263\u201382.","journal-title":"Acta Neuropathol"},{"key":"2105_CR69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.expneurol.2016.09.012","volume":"286","author":"S Casacuberta-Serra","year":"2016","unstructured":"Casacuberta-Serra S, Costa C, Eixarch H, Mansilla MJ, L\u00f3pez-Est\u00e9vez S, Martorell L, et al. Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis. Exp Neurol. 2016;286:50\u201360.","journal-title":"Exp Neurol"},{"key":"2105_CR70","doi-asserted-by":"crossref","first-page":"104869","DOI":"10.1016\/j.nbd.2020.104869","volume":"140","author":"C Melero-Jerez","year":"2020","unstructured":"Melero-Jerez C, Alonso-G\u00f3mez A, Mo\u00f1ivas E, Lebr\u00f3n-Gal\u00e1n R, Mach\u00edn-D\u00edaz I, de Castro F, et al. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis. Neurobiol Dis. 2020;140:104869.","journal-title":"Neurobiol Dis"},{"key":"2105_CR71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-023-02743-8","volume":"20","author":"X Cheng","year":"2023","unstructured":"Cheng X, Chi L, Lin T, Liang F, Pei Z, Sun J, et al. Exogenous monocyte myeloid-derived suppressor cells ameliorate immune imbalance, neuroinflammation and cognitive impairment in 5xFAD mice infected with Porphyromonas gingivalis. J Neuroinflammation. 2023;20:55.","journal-title":"J Neuroinflammation"},{"key":"2105_CR72","doi-asserted-by":"crossref","first-page":"e1413520","DOI":"10.1080\/2162402X.2017.1413520","volume":"7","author":"M Shen","year":"2018","unstructured":"Shen M, Wang J, Yu W, Zhang C, Liu M, Wang K, et al. A novel MDSC-induced PD-1\u2212 PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties. Oncoimmunology. 2018;7:e1413520.","journal-title":"Oncoimmunology"},{"key":"2105_CR73","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fimmu.2019.01242","volume":"10","author":"S Pesce","year":"2019","unstructured":"Pesce S, Greppi M, Grossi F, Del Zotto G, Moretta L, Sivori S, et al. PD\/1-PD-Ls checkpoint: insight on the potential role of NK cells. Front Immunol. 2019;10:1242.","journal-title":"Front Immunol"},{"key":"2105_CR74","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother. 2019;15:1111\u201322.","journal-title":"Hum Vaccin Immunother"},{"key":"2105_CR75","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","volume":"125","author":"D Marvel","year":"2015","unstructured":"Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015;125:3356\u201364.","journal-title":"J Clin Invest"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02105-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02105-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02105-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:55:57Z","timestamp":1767200157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02105-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2105"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02105-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was formally approved by the Ethical Review Board of the First Affiliated Hospital of Harbin Medical University (No: IRB-AF\/SC-04\/02.0). All participants provided written informed consent prior to inclusion. The study strictly adhered to ethical guidelines and protocols to ensure compliance with regulatory standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"136"}}